Max Healthcare Infuses ₹87.87 Cr in Subsidiary Kalinga Hospital

Max Healthcare Institute Ltd announced that its Renewable Energy and Subsidiary Investment Committee (RESIC) has approved an infusion of approximately ₹87.87 Crore into its subsidiary, Kalinga Hospital Ltd. This capital will be provided through a subscription to equity shares on a rights basis. The funds are intended to support Kalinga Hospital's capital expenditure, modernization program, strengthen its clinical and operational capabilities, optimize its capital structure, and meet general corporate requirements. The transaction is expected to be completed within the next 15 days. Kalinga Hospital Ltd reported a revenue of approximately ₹155.64 Crore for FY 2025-26 and has a paid-up capital of ₹21.54 Crore.